20948700

Source:http://linkedlifedata.com/resource/pubmed/id/20948700

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0001699, umls-concept:C0021311, umls-concept:C0678226, umls-concept:C1273870
pubmed:dateCreated	2010-10-15
pubmed:abstractText	The emergence of the Klebsiella pneumoniae carbapenemases in K. pneumoniae and other Gram-negative bacteria, usually on a background of multidrug resistance, has led to difficult therapeutic choices. Among available antibiotics, tigecycline and the polymyxins are the most frequently active against these organisms in vitro. Optimal therapy of infections due to these bacteria may involve maximization of antibiotic dose as well as their use in combination.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101506841
pubmed:status	PubMed-not-MEDLINE
pubmed:issn	1757-5931
pubmed:author	pubmed-author:DeresinskiStanley CSC, pubmed-author:SchirmerPatriciaP
pubmed:issnType	Electronic
pubmed:volume	1
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:year	2009
pubmed:articleTitle	Management of infections due to KPC-producing Klebsiella pneumoniae.
pubmed:publicationType	Journal Article